'Designer Babies': The Ultimate Privileged Elite?
By Heather Long,
Guardian
| 07. 09. 2013
When the world looks back at how the "designer babies" trend began, they will see an innocent start.
A Philadelphia couple who had gone through the physical and emotional marathon of trying to have a child turned to intra-uterine insemination and ultimately IVF. Like any rational people, they wanted to do everything to increase their chances that IVF would work. In this case, they sent the embryos to an Oxford lab, which ran a kind of
minimal DNA test to see which embryos would be most likely to take.
It's hard to deny this Philadelphia couple the chance to be parents. David Levy and Marybeth Scheidts look very wholesome in their family photo holding their son Connor, born in May 2013. They clearly weren't trying to select the embryo with their preferred hair or eye color or other physical or mental traits. In fact, they didn't even have a full DNA analysis done, only a scan of the chromosomes, the structures that hold genes. This isn't Brave New World-esque test tube babies. It's a traditional family – with the best...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Antonio Regalado, MIT Technology Review | 10.31.2025
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology.
The new company, called Preventive, is...